Benepass $40M Series B to expand employer benefits platform

Benepass has closed a $40 million Series B to extend its benefits finance platform into larger, more complex employer accounts and broaden its suite of pre- and post-tax benefit tools. The round was led by Centana Growth Partners and included participation from FoW Partners, plus existing backers Portage Ventures and Threshold Ventures.

The fresh capital will accelerate product work aimed at giving employers tighter control over healthcare spending while increasing employee choice. That roadmap includes deeper investment in Health Savings Account functionality—such as integrated enrollment, employer-controlled investment options and a $125 minimum investment threshold—and an expanded set of Specialty Health Reimbursement Accounts targeted at high-cost therapy categories.

Benepass positions those specialty accounts as a tool for employers to contain the budgetary impact of rising drug and treatment costs—starting with GLP-1 weight‑management medicines—by letting employers define eligible drugs, restrict merchants and pair medication coverage with complementary services like nutrition and behavioural coaching. The model aims to support targeted care without broadly lifting premiums or deductibles for the entire workforce.

Executives framed the round against a backdrop of mounting healthcare inflation. With industry estimates suggesting medical spending growth could reach double digits in the near term, benefits administrators and HR teams are actively seeking ways to optimise plan design and boost employee participation in pre-tax accounts. Benepass CEO Jaclyn Chen said consolidating multiple benefit vehicles on a single ledgered platform helps make benefits easier to understand and more likely to be used.

Benepass highlighted customer traction as evidence for investor confidence: the company supports more than 250 employers globally, has processed over 4.5 million card transactions, and reports revenue growth that has more than doubled since January 2025. The firm is also integrated into enterprise HR ecosystems as a strategic partner for financial benefits, signalling growing demand among larger buyers for compliant, flexible benefits infrastructure.

From a market perspective, the deal sits at the intersection of two fast-moving trends: employers shifting cost-management upstream into plan design and the broader fintechification of workplace benefits. Pre-tax accounts such as HSAs and FSAs remain attractive because they reduce employees’ taxable income and shrink employers’ payroll-tax liabilities—creating a structural incentive to encourage uptake as overall healthcare costs rise.

For investors, the attraction is a company that blends regulatory compliance, payments rails and benefit-plan configurability—capabilities that become stickier as employers integrate benefits into total rewards and payroll systems. With funding from Centana Growth Partners, FoW Partners, Portage Ventures and Threshold Ventures, Benepass aims to scale its product for enterprise customers while deepening member engagement and speciality program coverage.

The new capital should enable the company to expand sales and product teams, accelerate partnerships with payroll and HR platforms, and refine analytics that help employers measure the ROI of targeted benefit programs as healthcare costs continue to climb.